Study of High Efficient Killing Cell Therapy for Advanced NSCLC

Exclusion Criteria

• •Pregnant and lactating women.
• •Patients with T cell lymphoma, syphilis, AIDS or combination
• •Patients with highly allergic or have a history of severe allergies
• •Patients with severe hepatic or renal dysfunction
• •Patients with severe autoimmune disease or who is being treated with immunosuppressive agents
• •Patients with severe infection not controlled or High fever
• •Patients with organ transplantation or waiting for organ transplantation.
• •Patients with brain metastasis
• •Patients with severe coagulopathy (e.g. hemophilia)
• •Patients without adequate ability to understand, sign informed consents and take part in the clinical research voluntarily.